Stock Price
28.65
Daily Change
0.53 1.88%
Monthly
-11.38%
Yearly
-16.03%
Q1 Forecast
27.48



Peers Price Chg Day Year Date
Ansell 28.65 0.53 1.88% -16.03% Mar/25
Cochlear 165.63 4.25 2.63% -38.41% Mar/25
CSL 140.99 1.60 1.15% -44.26% Mar/25
Fisher Paykel Healthcare 37.19 1.01 2.79% 7.49% Mar/25
Amotiv 6.29 0.13 2.11% -33.09% Mar/25
Healius 0.58 0.04 6.48% -56.11% Mar/25
Integral Diagnostics 2.36 0 0% 2.16% Mar/25
Mayne Pharma 2.32 0.07 3.11% -67.91% Mar/25
Nanosonics 3.63 0.12 3.42% -20.57% Mar/25
Polynovo 0.90 0.02 1.70% -28.11% Mar/25

Indexes Price Day Year Date
ASX200 8519 154.95 1.85% 6.50% Mar/25
ASX All Share 8745 173.96 2.03% 6.32% Mar/25

Ansell traded at 28.65 this Wednesday March 25th, increasing 0.53 or 1.88 percent since the previous trading session. Looking back, over the last four weeks, Ansell gained 11.38 percent. Over the last 12 months, its price fell by 16.03 percent. Looking ahead, we forecast Ansell to be priced at 27.48 by the end of this quarter and at 25.74 in one year, according to Trading Economics global macro models projections and analysts expectations.

Ansell Limited is an Australia-based safety protection solutions Company. It is engaged in development, manufacturing, sourcing, and distributing of gloves and personal protective equipments. The Company operates through two segments: Industrial Global Business Unit (GBU) and Healthcare Global Business Unit (GBU). Industrial GBU manufactures hand and chemical protective clothing solutions for industrial applications. Industrial GBU offers protective solutions to various industries such as automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil, and gas. Healthcare GBU manufactures surgical and examination gloves, healthcare safety devices and infection prevention products for healthcare professionals and patients and single use industrial application gloves. Healthcare GBU offers solutions to customers including hospitals, dental surgeries, veterinary clinics, auto repair shops, chemical plants, laboratories, and pharmaceutical companies.